Organogenesis Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

1.40$ -0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Organogenesis Holdings Inc (ORGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 406 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ORGO
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	302	311	311	312	312	313	314	315	316	164	176	168	175	221	208	216	246	290	319	356	370	443	436	456	457	449	446	450	463	460	458	443	446	498	467	461	510	599	520	406
Current Assets	1.7	1.4	0.9	0.6	0.4	0.3	0.3	0.2	0.0	71	85	76	81	126	111	118	129	174	185	202	212	227	218	232	231	223	217	216	226	225	227	234	239	286	268	260	300	362	269	200
Cash	1.7	1.0	0.5	0.3	0.1	0.1	0.1	0.1	0.0	21	31	20	23	60	47	40	37	84	77	90	102	114	108	112	107	102	89	89	98	104	89	90	94	136	110	73	64	94	92	46
Cash & Short-Term Investments	1.7	1.0	0.5	0.3	0.1	0.1	0.1	0.1	0.0	21	31	20	23	60	47	40	37	84	77	90	102	114	108	112	107	102	89	89	98	104	89	90	94	136	110	73	64	94	92	46
Receivables	–	–	0.4	0.6	0.0	8.5	0.3	23	29	34	33	34	34	39	33	44	57	57	72	77	75	82	79	89	93	89	92	94	89	82	96	106	101	110	103	120	169	217	117	101
Inventory	–	–	0.4	0.3	0.2	4.3	-0.3	14	12	13	18	19	20	23	26	29	30	28	30	28	29	25	23	23	25	25	26	25	28	28	28	27	27	26	29	33	40	30	28	29
Property, Plant & Equipment	–	–	–	–	5.2	13	41	41	41	40	39	41	44	47	50	53	56	60	62	96	75	79	84	93	97	102	107	155	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	3.1	7.7	26	26	26	26	26	26	26	26	26	26	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29
Intangible Assets	–	–	–	–	3.6	9.0	28	28	27	26	25	24	22	21	20	19	32	31	29	28	27	26	24	23	22	21	20	18	17	16	15	14	13	12	12	11	9.9	9.1	3.4	3.0
Total Liabilities	11	11	11	11	14	15	16	17	13	117	144	145	162	165	168	181	181	148	162	177	181	202	193	202	201	184	182	179	186	181	180	180	168	113	99	100	124	165	139	118
Current Liabilities	0.6	0.5	0.1	0.1	2.7	3.9	5.1	5.9	8.0	66	52	50	57	60	55	66	66	68	74	85	81	83	77	88	89	75	76	73	81	81	83	86	77	77	65	66	90	100	76	57
Short-Term Debt	0.3	–	–	–	0.0	5.5	0.3	0.5	0.7	4.8	2.3	2.4	2.9	3.1	4.9	10.0	15	20	25	31	15	15	15	19	20	16	19	20	22	20	22	20	18	9.1	9.3	9.8	9.8	19	9.7	9.3
Accounts Payable	0.5	–	–	–	2.3	19	27	27	19	19	25	22	28	28	26	30	24	23	24	27	28	29	28	36	38	32	30	27	27	31	23	29	24	29	25	30	40	32	29	29
Long-Term Debt	–	–	–	–	11	27	83	83	108	39	71	73	83	83	91	92	87	53	53	47	72	71	70	69	68	66	65	63	62	61	59	58	56	–	–	–	–	–	–	–
Shareholders' Equity	291	300	300	301	299	298	298	298	303	47	33	23	13	56	40	36	65	142	157	179	189	241	243	254	256	266	264	271	277	279	278	264	279	385	368	361	386	434	381	288
Retained Earnings	-0.1	-0.2	-0.1	0.3	-1.8	-2.3	-2.5	-2.1	2.8	-130	-146	-155	-167	-171	-187	-192	-172	-155	-141	-120	-112	-61	-60	-53	-53	-45	-49	-44	-40	-41	-43	-60	-48	-40	-59	-68	-47	-3.1	-56	-153
Shares Outstanding	8.6	7.9	9.2	9.3	9.3	9.3	64	66	69	77	91	91	92	98	104	105	108	121	133	134	134	133	133	133	132	132	131	133	133	132	132	133	134	132	126	127	131	132	128	129

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings